1. Zn(II) complexes of (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline in combination with non-steroidal anti-inflammatory drug sodium diclofenac: Structure, DNA binding and photo-cleavage studies, antioxidant activity and interaction with albumin.
- Author
-
Kakoulidou C, Gritzapis PS, Hatzidimitriou AG, Fylaktakidou KC, and Psomas G
- Subjects
- Animals, Antioxidants chemistry, Antioxidants pharmacology, Cattle, Crystallography, X-Ray methods, DNA chemistry, Diclofenac pharmacology, Free Radical Scavengers chemistry, Intercalating Agents chemistry, Intercalating Agents pharmacology, Quinazolines chemistry, Quinazolines pharmacology, Serum Albumin, Bovine metabolism, Zinc Compounds pharmacology, Anti-Inflammatory Agents, Non-Steroidal chemistry, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Coordination Complexes chemistry, Coordination Complexes pharmacology, DNA metabolism, Diclofenac chemistry, Zinc Compounds chemistry
- Abstract
The interaction of the novel quinazoline (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline (L) with Zn
2+ was performed in the absence or presence of the non-steroidal anti-inflammatory drug sodium diclofenac (Nadicl) and resulted in the formation of complexes [Zn(L)2 ](NO3 )2 ·MeOH (1·MeOH) and [Zn(L)(dicl-O)2 ]·MeOH (2·MeOH), respectively. The two complexes were characterized by IR and1 H NMR spectroscopy and by single-crystal X-ray crystallography. In these complexes, L was tridentately coordinated to Zn(II) via the quinazoline, hydrazone and pyridine nitrogen atoms. Further studies concerning the behavior of the compounds towards calf-thymus (CT) DNA and supercoiled circular pBluescript KS II plasmid DNA (pDNA) have been performed. The complexes may bind to CT DNA via intercalation, with complex 1 showing higher binding affinity than 2. The complexes may cleave pDNA in the absence or presence of irradiation with UVA, UVB or visible light and the most active pDNA-cleavager is compound 1. The binding constants of the compounds for bovine serum albumin were calculated and the subdomain of the albumin where the compounds prefer to bind was determined. The free radical scavenging ability of the compounds was evaluated towards 1,1-diphenyl-picrylhydrazyl and 2,2΄-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) radicals with complex 2 being the most active compound. Thus, complex of type 1 maybe a lead compound for the development of novel DNA-binders and DNA-cleavers or photo-cleavers for medical and biotechnological "on demand" applications, whereas the structure of complex type 2 may provide novel antioxidants and radical scavengers., Competing Interests: Declaration of competing interest There are no conflicts to declare., (Copyright © 2020 Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF